Venrock

Activity from announced rounds

Activity in this selectionApr 30, 2026 · Apr 1, 2026

Venrock is the venture manager whose own Encoded portfolio identifies investor Bryan Roberts.

Recorded funding activity

Encoded develops neurological gene therapies. Other recorded companies include Gitar’s software-review agents and Adcendo’s targeted cancer medicines. Venrock Healthcare Capital Partners remains a separate manager identity.

Sources
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$84M
2 disclosed · full round size, not this investor’s share

By stage

Series C+1
Undisclosed1

By primary sector

Biotech1
Enterprise software1

By country

Denmark1
United States1

Rounds

2 in this selection
Gitar

Builds AI agents for code review and continuous integration workflows

$9MUndisclosed
Role not disclosed
Adcendo

Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.

$75MSeries C
Role not disclosed